Literature DB >> 3278786

Pharmacodynamic basis for altered drug action in the elderly.

J Roberts1, N Tumer.   

Abstract

The elderly have the highest incidence of medical and psychiatric disorders. These conditions frequently occur simultaneously and are often chronic, lasting the lifetime of the individual. Consequently, the elderly require more medications than do younger patients. Consumption of over-the-counter drugs is considerable among the aged. There is considerable evidence that the elderly patient in most cases responds differently to drugs than do young adults. Many factors contribute to these differences. Among them are reduced protein binding, reduced biotransformation, diminished renal elimination, changes in receptor density or affinity, or both, diminished receptor adaptability, changes in the coupling between receptors and effector systems, impairment of responding organs resulting from the pathologic state, reduction in the reactivity of homeostatic mechanisms, and the aging process itself. These components may have different weight, depending on the drug and the individual considered. Because of the physiologic age-related changes in the distribution and elimination of drugs and in the sensitivity to medications, adverse side effects develop frequently in the elderly. Accordingly, dosages and dosage intervals must be adjusted carefully. In addition, since the elderly often take multiple medications, they frequently experience ADRs. Psychotropic drugs are often involved in such interactions and cause twice the incidence of side effects in elderly patients as they do in younger patients. Drug-nutrient and drug-drug interactions, programs to enhance patient compliance, and sociogenic factors should be taken into account in any well-designed dose regimen for the elderly. Physician awareness of problems that exist in the elderly population's use of drugs is essential if rational drug therapy for the aged is to evolve. The proper use of drugs in the elderly largely depends on taking into account both the pharmacokinetic and the pharmacodynamic properties of the drug and how these parameters are altered with age; such information can be obtained only by investigating drug action in older people.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3278786

Source DB:  PubMed          Journal:  Clin Geriatr Med        ISSN: 0749-0690            Impact factor:   3.076


  6 in total

Review 1.  Physiological changes due to age. Pharmacodynamic changes of drug action and implications for therapy.

Authors:  P P Lamy
Journal:  Drugs Aging       Date:  1991 Sep-Oct       Impact factor: 3.923

Review 2.  Age-related changes in the gastrointestinal system. Effects on drug therapy.

Authors:  F L Iber; P A Murphy; E S Connor
Journal:  Drugs Aging       Date:  1994-07       Impact factor: 3.923

Review 3.  Review of topiramate for the treatment of epilepsy in elderly patients.

Authors:  B R Sommer; H H Fenn
Journal:  Clin Interv Aging       Date:  2010-04-26       Impact factor: 4.458

4.  Effect of age on the pharmacokinetics of duloxetine in women.

Authors:  Michael H Skinner; Han-Yi Kuan; Andrej Skerjanec; Mary E Seger; Michael Heathman; Lisa O'Brien; Shobha Reddy; Mary P Knadler
Journal:  Br J Clin Pharmacol       Date:  2004-01       Impact factor: 4.335

Review 5.  Distinguishing between the fit and frail elderly, and optimising pharmacotherapy.

Authors:  N J Owens; M D Fretwell; C Willey; S S Murphy
Journal:  Drugs Aging       Date:  1994-01       Impact factor: 3.923

6.  Psychometric properties of the eight-item Morisky Medication Adherence Scale (MMAS-8) in a psychiatric outpatient setting.

Authors:  Carlos De Las Cuevas; Wenceslao Peñate
Journal:  Int J Clin Health Psychol       Date:  2014-12-25
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.